Table 8 Comparing Mean PASI Score, BSA Reduction, and Treatment Cost: Assumptions of Weekly Dosing and Cheapest Biosimilar for Adalimumab with a 40% Risankizumab Price Discount (Risankizumab N = 30 vs. Adalimumab N = 40)
| Â | Risankizumab | Adalimumab | Mean difference (95% confidence interval) |
|---|---|---|---|
Cost of treatment (USD), mean ± SD | 10787.41 ± 3170.08 | 10767.40 ± 1008.35 | 20.01(-1140.65–683.031) |
Difference in PASI (%) | 87.373 ± 25.938 | 74.499 ± 36.143 | 12.88(1.271–24.934) |